Waterfront Wealth’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,654
| Closed | -$215K | – | 271 |
|
|
2025
Q1 | $215K | Hold |
2,654
| – | – | 0.05% | 246 |
|
|
2024
Q4 | $239K | Buy |
2,654
+100
| +4% | +$9.01K | 0.06% | 236 |
|
|
2024
Q3 | $252K | Hold |
2,554
| – | – | 0.06% | 231 |
|
|
2024
Q2 | $237K | Sell |
2,554
-750
| -23% | -$69.5K | 0.06% | 225 |
|
|
2024
Q1 | $271K | Buy |
3,304
+300
| +10% | +$24.6K | 0.08% | 214 |
|
|
2023
Q4 | $268K | Buy |
+3,004
| New | +$268K | 0.08% | 214 |
|
|
2023
Q3 | – | Sell |
-3,504
| Closed | -$292K | – | 256 |
|
|
2023
Q2 | $292K | Sell |
3,504
-100
| -3% | -$8.34K | 0.09% | 203 |
|
|
2023
Q1 | $275K | Hold |
3,604
| – | – | 0.09% | 209 |
|
|
2022
Q4 | $322K | Sell |
3,604
-1,250
| -26% | -$112K | 0.11% | 196 |
|
|
2022
Q3 | $397K | Sell |
4,854
-803
| -14% | -$65.7K | 0.15% | 168 |
|
|
2022
Q2 | $420K | Buy |
5,657
+1,195
| +27% | +$88.7K | 0.17% | 159 |
|
|
2022
Q1 | $408K | Buy |
4,462
+1,983
| +80% | +$181K | 0.14% | 155 |
|
|
2021
Q4 | $278K | Buy |
+2,479
| New | +$278K | 0.11% | 180 |
|